Subsequently, the retrospective study of Tesselaar and colleagues suggested that the activity of TF-bearing MPs was significantly higher in cancer patients compared with healthy controls and cancer patients with VTE had higher TF-bearing MPs activity than cancer patients without VTE36. The gene discussed is TF; the disease is cancer.